Hims CEO Says He ‘Won’t Cave’ to Novo Demands Over Copycat Shots

Hims & Hers Health Inc. won’t back down from selling cheap weight-loss shots, its chief executive officer said one day after Novo Nordisk A/S abruptly ended its distribution partnership.

“We’re upset that Novo is feeling the pressure and not comfortable, but ultimately, I think us holding strong to fighting on behalf of customers is just who we are,” Hims CEO Andrew Dudum said Tuesday in his first interview since the news broke. “There’s just no way in hell we’re going to cave on that, no matter who the pharma company is or what the partnership looks like.”

Novo terminated its ...